Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium.

نویسندگان

  • Brian M Wolpin
  • Peter Kraft
  • Mousheng Xu
  • Emily Steplowski
  • Martin L Olsson
  • Alan A Arslan
  • H Bas Bueno-de-Mesquita
  • Myron Gross
  • Kathy Helzlsouer
  • Eric J Jacobs
  • Andrea LaCroix
  • Gloria Petersen
  • Rachael Z Stolzenberg-Solomon
  • Wei Zheng
  • Demetrius Albanes
  • Naomi E Allen
  • Laufey Amundadottir
  • Melissa A Austin
  • Marie-Christine Boutron-Ruault
  • Julie E Buring
  • Federico Canzian
  • Stephen J Chanock
  • J Michael Gaziano
  • Edward L Giovannucci
  • Göran Hallmans
  • Susan E Hankinson
  • Robert N Hoover
  • David J Hunter
  • Amy Hutchinson
  • Kevin B Jacobs
  • Charles Kooperberg
  • Julie B Mendelsohn
  • Dominique S Michaud
  • Kim Overvad
  • Alpa V Patel
  • Maria-José Sanchéz
  • Leah Sansbury
  • Xiao-Ou Shu
  • Nadia Slimani
  • Geoffrey S Tobias
  • Dimitrios Trichopoulos
  • Paolo Vineis
  • Kala Visvanathan
  • Jarmo Virtamo
  • Jean Wactawski-Wende
  • Joanne Watters
  • Kai Yu
  • Anne Zeleniuch-Jacquotte
  • Patricia Hartge
  • Charles S Fuchs
چکیده

BACKGROUND Subjects with non-O ABO blood group alleles have increased risk of pancreatic cancer. Glycosyltransferase activity is greater for the A(1) versus A(2) variant, whereas O01 and O02 variants are nonfunctioning. We hypothesized: 1) A(1) allele would confer greater risk than A(2) allele, 2) protective effect of the O allele would be equivalent for O01 and O02 variants, 3) secretor phenotype would modify the association with risk. METHODS We determined ABO variants and secretor phenotype from single nucleotide polymorphisms in ABO and FUT2 genes in 1,533 cases and 1,582 controls from 12 prospective cohort studies. Adjusted odds ratios (OR) for pancreatic cancer were calculated using logistic regression. RESULTS An increased risk was observed in participants with A(1) but not A(2) alleles. Compared with subjects with genotype O/O, genotypes A(2)/O, A(2)/A(1), A(1)/O, and A(1)/A(1) had ORs of 0.96 (95% CI, 0.72-1.26), 1.46 (95% CI, 0.98-2.17), 1.48 (95% CI, 1.23-1.78), and 1.71 (95% CI, 1.18-2.47). Risk was similar for O01 and O02 variant O alleles. Compared with O01/O01, the ORs for each additional allele of O02, A(1), and A(2) were 1.00 (95% CI, 0.87-1.14), 1.38 (95% CI, 1.20-1.58), and 0.96 (95% CI, 0.77-1.20); P, O01 versus O02 = 0.94, A(1) versus A(2) = 0.004. Secretor phenotype was not an effect modifier (P-interaction = 0.63). CONCLUSIONS Among participants in a large prospective cohort consortium, ABO allele subtypes corresponding to increased glycosyltransferase activity were associated with increased pancreatic cancer risk. IMPACT These data support the hypothesis that ABO glycosyltransferase activity influences pancreatic cancer risk rather than actions of other nearby genes on chromosome 9q34.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium.

There is strong epidemiologic evidence indicating that common genetic variability could be implicated in pancreatic cancer risk and, to date, various loci have been proposed. In particular, there is increasing evidence of the involvement of ABO gene variability and pancreatic cancer risk. In a large multicentric study of 1,028 pancreatic ductal ad...

متن کامل

Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium.

A recent genome-wide association study (PanScan) identified significant associations at the ABO gene locus with risk of pancreatic cancer, but the influence of specific ABO genotypes remains unknown. We determined ABO genotypes (OO, AO, AA, AB, BO, and BB) in 1,534 cases and 1,583 controls from 12 prospective cohorts in PanScan, grouping participants by genotype-derived serologic blood type (O,...

متن کامل

Relationship between ABO Blood Group Antigens and Pancreatic Cancer-Systemic Review

Pancreatic cancer is among the most aggressive types of cancer. It has mortality rates as the seventh most frequent cause of cancer death worldwide. The association between ABO blood group and risk of pancreatic cancer has been known for more than 40 years.Various studies, in detail, although conflicting on many occasions, on large population groups, cohort studies, case-control studies, retros...

متن کامل

Association between alcohol consumption and pancreatic cancer: a systematic review of cohort studies

Background: Among all types of cancers, pancreatic cancer has poor prognosis with 5-year survival below 10%. In theory, alcohol intake may be a modifiable risk factor for pancreatic cancer due to its role in multiple carcinogenic and metabolic signaling pathways. In addition, alcohol consumption may lead to chronic pancreatitis which is underlying cause of pancreatic cancer. However, little is ...

متن کامل

Re: ABO blood group and the risk of pancreatic cancer.

BACKGROUND Other than several rare, highly penetrant familial syndromes, genetic risk factors for sporadic pancreatic cancer are largely unknown. ABO blood type is an inherited characteristic that in previous small studies has been associated with the risk of gastrointestinal malignancies. METHODS We separately examined the relationship between ABO blood type and the risk of incident pancreat...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

دوره 19 12  شماره 

صفحات  -

تاریخ انتشار 2010